Athersys
ATHX
#10968
Rank
HK$6.53 M
Marketcap
HK$0.11
Share price
-33.50%
Change (1 day)
-98.90%
Change (1 year)

Athersys (ATHX) - Cash on Hand

Cash on Hand as of September 2023 : HK$8 Million

According to Athersys's latest financial reports the company has HK$8 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Athersys - Cash on Hand chart (from 2006 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31HK$70.61 M-75.79%
2021-12-31HK$0.29 B-27.01%
2020-12-31HK$0.39 B46.42%
2019-12-31HK$0.27 B-31.75%
2018-12-31HK$0.39 B74.57%
2017-12-31HK$0.22 B100.21%
2016-12-31HK$0.11 B-35.9%
2015-12-31HK$0.17 B-11.93%
2014-12-31HK$0.20 B-18.2%
2013-12-31HK$0.24 B25.18%
2012-12-31HK$0.19 B99.32%
2011-12-31HK$99.29 M-15.96%
2010-12-31HK$0.11 B-28.47%
2009-12-31HK$0.16 B-23.7%
2008-12-31HK$0.21 B-22.29%
2007-12-31HK$0.27 B
2003-12-31HK$0.14 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
HK$172.96 B 2,161,762.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$102.55 B 1,281,762.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$94.42 B 1,180,096.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$50.33 B 628,992.16%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$44.72 B 558,919.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$82.24 B 1,027,939.22%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
HK$3.00 B 37,465.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
HK$40.82 B 510,194.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA